Kamala Sundararaj, PhD is a Staff Scientist in Dr. Hobbs lab in the Department of Cell and Molecular Pharmacology and Experimental Therapeutics at MUSC. She completed her Doctor of Philosophy in Biochemistry and she has engaged in scientific investigations for several years. Dr. Sundararaj works with Dr. Hobbs and her study is focused on KRAS mutations in PDAC particularly identifying a therapeutic approach specific for G12R KRAS mutations in PDAC. Dr. Sundararaj has research experience in cancer biology, biochemistry and immunology and has scientific publications in prestigious journals. Her expertise in scientific research, specifically in the field of signal transduction and Immunology will greatly enhance value to the studies proposed for how KRAS G12R allele-specific metabolic reprogramming alters therapeutic sensitivity.